Early research (Phase 1)Study completedNCT02172274What this trial is testingBI 10773 Administered as Oral Solution to Healthy Male VolunteersWho this might be right forHealthy Boehringer Ingelheim 8
Large-scale testing (Phase 3)Study completedNCT04509674What this trial is testingEMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)Who this might be right forMyocardial Infarction Boehringer Ingelheim 6,522
Post-approval studies (Phase 4)Not Yet RecruitingNCT07180745What this trial is testingEmpagliflozin Versus Statins in Non-Alcoholic Fatty Liver DiseaseWho this might be right forNon-alcoholic Fatty Liver Disease NAFLDNon-alcoholic Steatohepatitis NASH Badr University 400
Post-approval studies (Phase 4)UnknownNCT01001962What this trial is testingDouble Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II DiabeticsWho this might be right forHypertensionType II Diabetes Aristotle University Of Thessaloniki 1,054
Post-approval studies (Phase 4)UnknownNCT05200793What this trial is testingEfficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary SyndromeWho this might be right forPolycystic Ovary Syndrome (PCOS) Alexandria University 75
Not applicableStudy completedNCT04918407What this trial is testingEffects of Empagliflozin in Reducing Oxidative Stress After Kidney TransplantationWho this might be right forKidney Transplant; Complications Shahid Beheshti University of Medical Sciences 40
Post-approval studies (Phase 4)Ended earlyNCT02728453What this trial is testingSGLT2 Inhibition and Left Ventricular MassWho this might be right forDiabetes Mellitus Type 2 Hannover Medical School 7
Post-approval studies (Phase 4)UnknownNCT04583813What this trial is testingEmpagliflozin and Atrial Fibrillation TreatmentWho this might be right forAtrial FibrillationHeart FailureObesity+1 more Miulli General Hospital 400
Post-approval studies (Phase 4)UnknownNCT02964715What this trial is testingThe Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 DiabetesWho this might be right forType2 DiabetesNAFLD University of Malaya 25
Early research (Phase 1)Study completedNCT02577315What this trial is testingDemonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed ConditionsWho this might be right forHealthy Boehringer Ingelheim 25
Post-approval studies (Phase 4)Looking for participantsNCT05671991What this trial is testingEffect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal DiseaseWho this might be right forEnd Stage Renal Disease on Dialysis Yale University 30
Large-scale testing (Phase 3)Study completedNCT01306214What this trial is testingSafety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes MellitusWho this might be right forDiabetes Mellitus, Type 2Obesity Boehringer Ingelheim 566
Early research (Phase 1)Study completedNCT04450563What this trial is testingLow Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin SystemWho this might be right forType 1 Diabetes McGill University 25
Testing effectiveness (Phase 2)UnknownNCT06012266What this trial is testingRepurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose RationaleWho this might be right forHeart Failure Centre Hospitalier Universitaire Vaudois 12
Testing effectiveness (Phase 2)Study completedNCT05977465What this trial is testingEmpagliflozin in Treatment of Peripheral Diabetic NeuropathyWho this might be right forDiabetic Neuropathy Peripheral Tanta University 50
Large-scale testing (Phase 3)Study completedNCT04233801What this trial is testingTest How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take InsulinWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 219
Very early researchUnknownNCT04203927What this trial is testingEffects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 DiabetesWho this might be right forType2 DiabetesInsulin Sensitivity University of Virginia 50
Early research (Phase 1)Study completedNCT02782624What this trial is testingRelative Bioavailability of BI 10773 Administered Twice Daily Compared BI 10773 Given Once Daily After Multiple Oral Doses in Healthy Male and Female VolunteersWho this might be right forHealthy Boehringer Ingelheim 16
Testing effectiveness (Phase 2)Study completedNCT05084235What this trial is testingThe Cardiac Effects of Empagliflozin in Patients With High Risk of Heart FailureWho this might be right forHeart FailureObesity Jacob Moller 191
Early research (Phase 1)Study completedNCT05823870What this trial is testingThis Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition.Who this might be right forHealthy Subjects Dong Wha Pharmaceutical Co. Ltd. 32